Tandem Diabetes Care, Inc. (TNDM)

NASDAQ: TNDM · USD

$19.7

+0.44 (+2.3%)· Recorded snapshot

Market cap	1.4B
Revenue (ttm)	1B
Net income (ttm)	-63.3M
EPS (ttm)	-$0.93
Shares out	69.6M
Volume	1,688,676
Beta	1.66

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1B
Net income (ttm): -63.3M
EPS (ttm): -$0.93
Market cap: 1.4B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantener

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.4P50 20.2P75 35.7

Trailing P/En/a

P25 15.4P50 25.8P75 43.5

ROE-48

P25 -113.8P50 -46.5P75 -0.9

ROIC-12.1

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All TNDM indicators

Market & fundamental data

Available fields

219

Groups with data

Currency

USD

Showing 219 of 219 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001438133
Company name	Tandem Diabetes Care, Inc.
Country	United States
Country code	US
CUSIP number	875372203
Earnings date	2026-11-05
Earnings time	amc
Employees	2,500
Employees change	-150
Employees growth	-5.66%
Enterprise value	$1.7B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2006
In index	RUSSELL2000
Industry	Medical Devices
IPO date	2013-11-14
Is primary listing	Yes
Is SPAC	No
ISIN number	US8753722037
Last 10-K release date	2026-02-19
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split date	2017-10-10
Last stock split type	Reverse
Market cap	$1.4B
Market cap category	Small-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$19.66
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	TNDM
U.S. state	California
Website	https://www.tandemdiabetes.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-4.72%
EV/Sales	1.57x
FCF / EV yield	-1.63%
FCF yield	-1.97%
Forward EV/Sales	1.44x
Forward P/S	1.19x
Industry forward P/E	19.81x
Industry P/E	39.28x
P/B ratio	10.25x
P/S ratio	1.3x
Price / tangible book value	10.37x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-4.13%
EBITDA margin	-2.4%
Gross margin	56.01%
Operating margin	-4.13%
Pretax margin	-5.86%
Profit margin	-6.08%
Profit per employee	$-25,326
Revenue per employee	$416,567
ROA	-2.65%
ROA (5Y)	-4.54%
ROCE	-4.77%
ROE	-48.03%
ROE (5Y)	-41.61%
ROIC	-12.1%
ROIC (5Y)	-25.83%
SBC / revenue	6.98%
Tax / revenue	0.22%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	2
EPS growth years	0
Gross profit growth	10.82%
Gross profit growth (Q)	15.04%
Gross profit growth 3Y	12.97%
Gross profit growth 5Y	12.65%
Net income growth quarters	2
Net income growth years	0
Revenue growth	3.96%
Revenue growth (Q)	5.77%
Revenue growth (QoQ)	2.97%
Revenue growth 10Y	28.05%
Revenue growth 3Y	9.63%
Revenue growth 5Y	11.48%
Revenue growth quarters	10
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-21.1M
Depreciation and amortization	$18M
EBIT	$-43M
EBITDA	$-25M
EPS	$-0.93
FCF per share	$-0.38
Financing cash flow	$277.3M
Free cash flow	$-26.6M
Free cash flow minus SBC	$-99.3M
Gross profit	$583.3M
Income taxes	$2.3M
Investing cash flow	$-277.2M
Net borrowing	$300M
Net cash flow	$-1.3M
Net income	$-63.3M
Operating cash flow minus SBC	$-78.2M
Operating income	$-43M
Revenue	$1B
Stock-based compensation	$72.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	0.49
Book value per share	$1.88
Debt / equity	5.67
Interest coverage	-4.89
Long-term assets	$349.6M
Long-term liabilities	$770.8M
Net cash (debt)	$-283.3M
Net cash / market cap	-20.94%
Net debt / equity	2.17
Piotroski F-Score	3
Property, plant and equipment	$184.7M
Shareholders' equity	$130.4M
Tangible book value	$130.4M
Tangible book value per share	$1.88
Total assets	$1.2B
Total cash	$456M
Total debt	$739.3M
Total liabilities	$1B
WACC	8.99%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.03
Current assets	$804.6M
Current liabilities	$253M
Current ratio	3.18
Inventory turnover	3.3
Net working capital	$115.9M
Quick ratio	2.44
Working capital	$551.6M
Working capital turnover	2.28

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-3.08%
Dividend yield	0%
Shareholder yield	-3.08%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-67.5%
10Y return CAGR	-10.63%
10Y total return	-67.5%
150-day SMA	$18.02
1D price change	2.29%
1M price change	24.05%
1M total return	24.05%
1W price change	18.04%
1W total return	18.04%
1Y price change	30.52%
1Y return CAGR	30.55%
1Y total return	30.52%
20-day SMA	$16.83
200-day SMA	$18.95
3M price change	13.57%
3M total return	13.57%
3Y price change	8.39%
3Y return CAGR	2.72%
3Y total return	8.39%
50-day SMA	$18.16
50-day SMA vs 200-day SMA	50under200
52-week high	$29.65
52-week high date	2026-02-24
52-week low	$12.26
52-week low date	2026-05-15
5Y price change	-85.02%
5Y return CAGR	-31.59%
5Y total return	-85.02%
6M price change	-1.61%
6M total return	-1.61%
All-time high	$302.50
All-time high date	2014-01-14
All-time low	$2.14
All-time low date	2018-02-09
Average true range (ATR)	$0.96
Average volume	2.1M
Beta (1Y)	-0.25
Beta (2Y)	0.57
Beta (5Y)	1.66
Change from 52-week high	-33.69%
Change from 52-week low	60.36%
Change from all-time high	-93.55%
Change from all-time low	811.21%
Change from open	3.53%
Day's gap	-1.2%
Dollar volume	$33.2M
High price	$19.69
Low price	$18.91
Monthly RSI	46.25
Open price	$18.99
Position in 52-week range	96.15%
Premarket change	2.19%
Premarket close	$19.22
Premarket price	$19.64
Premarket volume	997
Previous close	$19.22
Price vs 150-day SMA	8.2%
Price vs 20-day SMA	15.86%
Price vs 200-day SMA	2.92%
Price vs 50-day SMA	7.37%
Relative volume	0.8
RSI	68.49
Sharpe ratio	0.66
Sharpe ratio (3Y)	0.32
Sharpe ratio (5Y)	-0.25
Sortino ratio	1.25
Sortino ratio (3Y)	0.57
Sortino ratio (5Y)	-0.28
Volume	1.7M
Weekly RSI	53.43
YTD price change	-11.28%
YTD total return	-11.28%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	63.8M
Float percentage	91.63%
Shares change (QoQ)	0.9%
Shares change (YoY)	3.08%
Shares held by insiders	1.01%
Shares held by institutions	108.39%
Shares outstanding	69.6M
Short % of float	20.97%
Short % of shares	19.21%
Short ratio	6.4 days

Deeper analysis on TNDM

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TNDM report

Is a complete TNDM research report available?

No complete published report is available for Tandem Diabetes Care, Inc. (TNDM) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Tandem Diabetes Care, Inc. (TNDM)

Price

Financial snapshot

Fair-value bridge

Latest news · TNDM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TNDM indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TNDM

Frequently asked questions